Japan, Oct. 30 -- GENMAB AS has got intellectual property rights for 'HUMANIZED OR CHIMERIC CD3 ANTIBODIES.' Other related details are as follows:

Application Number: JP,2022-109476

Category (FI): A61K39/395@N,C12Q1/04,G01N33/574@A,C12P21/08,C12N5/10,C12N15/63@Z,C12N15/13,C12N1/21,C12N1/19,C12N1/15,C12M1/34@F,C12M1/34@B,C07K16/46,C07K16/42,C07K16/28,A61P37/02,A61P35/00,A61P31/00,A61K49/00

Stage: Grant (IP right document published.)

Filing Date: July 7, 2022

Publication Date: Oct. 25, 2022

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....